New York City Mayor Bill de Blasio announced that the city is investing $38 million in new biotech research and development centers at four institutions, including Columbia University, in an effort to transform New York City into the “public health capital of the world.”
Up to $9 million will be invested in Columbia’s new Therapeutic Validation Center to establish research facilities aimed at turning early-stage research into new start-ups. The Center will use mass spectrometry imaging technology “to create next-generation medicines that work by analyzing and orchestrating the behavior of individual cells in the human body to work in concert to eliminate disease.” It will be housed within existing facilities at Columbia and will be open to scientists and entrepreneurs from across the city.
Dr. Brent Stockwell, Professor of Biological Sciences, who will establish and lead the Center, says, “this new Center will allow researchers in NYC to overcome critical hurdles in launching blockbuster biotech companies that will create new medicines, further growing the NYC life science ecosystem.”
Announcement on the official website for the City of New York: https://www1.nyc.gov/office-of-the-mayor/news/047-21/state-the-city-preview-new-york-city-invests-38-million-new-biotech-centers